Abdullah Al‐Asmi

2.2k total citations
94 papers, 1.3k citations indexed

About

Abdullah Al‐Asmi is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Abdullah Al‐Asmi has authored 94 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 20 papers in Psychiatry and Mental health and 18 papers in Neurology. Recurrent topics in Abdullah Al‐Asmi's work include Multiple Sclerosis Research Studies (16 papers), Epilepsy research and treatment (15 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Abdullah Al‐Asmi is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), Epilepsy research and treatment (15 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Abdullah Al‐Asmi collaborates with scholars based in Oman, Australia and Kuwait. Abdullah Al‐Asmi's co-authors include Samir Al‐Adawi, François Dubeau, Musthafa Mohamed Essa, Selvaraju Subash, Ragini Vaishnav, Gilles J. Guillemin, Jean Gotman, Christian Bénar, Nady Braidy and Arunodaya R. Gujjar and has published in prestigious journals such as PLoS ONE, NeuroImage and Neurology.

In The Last Decade

Abdullah Al‐Asmi

84 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdullah Al‐Asmi Oman 19 329 275 211 168 155 94 1.3k
Danuta Ryglewicz Poland 27 196 0.6× 102 0.4× 63 0.3× 40 0.2× 49 0.3× 118 1.7k
Elyad Davidson Israel 22 86 0.3× 97 0.4× 185 0.9× 67 0.4× 51 0.3× 60 1.9k
Seong A. Shin South Korea 18 183 0.6× 117 0.4× 28 0.1× 98 0.6× 148 1.0× 41 985
Seung‐Hun Cho South Korea 23 120 0.4× 163 0.6× 40 0.2× 81 0.5× 38 0.2× 130 1.7k
Rubens José Gagliardi Brazil 16 130 0.4× 144 0.5× 50 0.2× 67 0.4× 25 0.2× 61 1.0k
M. Pappagallo United States 25 163 0.5× 259 0.9× 185 0.9× 24 0.1× 42 0.3× 81 2.4k
Maurizio Evangelista Italy 22 319 1.0× 128 0.5× 68 0.3× 36 0.2× 32 0.2× 54 1.1k
Yu-Hui Liu China 23 284 0.9× 105 0.4× 65 0.3× 31 0.2× 34 0.2× 73 1.9k
Anne Estrup Olesen Denmark 27 161 0.5× 473 1.7× 306 1.5× 20 0.1× 46 0.3× 123 2.7k
Ralf Uebelhack Germany 19 236 0.7× 92 0.3× 22 0.1× 104 0.6× 50 0.3× 69 1.2k

Countries citing papers authored by Abdullah Al‐Asmi

Since Specialization
Citations

This map shows the geographic impact of Abdullah Al‐Asmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Al‐Asmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Al‐Asmi more than expected).

Fields of papers citing papers by Abdullah Al‐Asmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Al‐Asmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Al‐Asmi. The network helps show where Abdullah Al‐Asmi may publish in the future.

Co-authorship network of co-authors of Abdullah Al‐Asmi

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Al‐Asmi. A scholar is included among the top collaborators of Abdullah Al‐Asmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Al‐Asmi. Abdullah Al‐Asmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeineddine, Maya, Raed Alroughani, Samar Farouk Ahmed, et al.. (2024). Safety and effectiveness of disease-modifying therapies after switching from natalizumab. Multiple Sclerosis Journal. 30(8). 1026–1035. 2 indexed citations
2.
Al‐Asmi, Abdullah, et al.. (2024). Seasonal Variations in Multiple Sclerosis Relapses in Oman: A Single Tertiary Centre Experience. International Journal of Environmental Research and Public Health. 21(10). 1371–1371. 1 indexed citations
3.
Gujjar, Arunodaya R., et al.. (2023). Developmental Venous Anomaly Presenting as an Acute Stroke Mimic. Cureus.
4.
Al‐Zakwani, Ibrahim, et al.. (2023). Association between Non-Steroidal Anti-Inflammatory Drug Use and Major Cardiovascular Outcomes in Patients with Acute Coronary Syndrome in the Arabian Gulf. Journal of Clinical Medicine. 12(17). 5446–5446. 2 indexed citations
5.
Al‐Asmi, Abdullah, et al.. (2023). Frequency of Dimethyl Fumarate-Induced Lymphopenia among Omani Patients with Multiple Sclerosis. Sultan Qaboos University medical journal. 24(1). 44–51. 2 indexed citations
6.
Al‐Asmi, Abdullah, et al.. (2023). Spinal Cord Infarct Due to Fibrocartilaginous Embolism in an Adolescent Boy: A Case Report and Literature Review. Cureus. 15(4). e37319–e37319. 1 indexed citations
7.
Al‐Asmi, Abdullah, Ali Hassan, Ahmed K. Bamaga, et al.. (2022). A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting. Journal of Neuromuscular Diseases. 9(5). 661–673. 4 indexed citations
8.
Al-Murshedi, Fathiya, Khalid Al‐Thihli, Abeer Al‐Saegh, et al.. (2022). The diagnostic yield, candidate genes, and pitfalls for a genetic study of intellectual disability in 118 middle eastern families. Scientific Reports. 12(1). 18862–18862. 12 indexed citations
9.
Nandhagopal, Ramachandiran, et al.. (2021). Epidemiology of multiple sclerosis in the Sultanate of Oman: A hospital based study. Multiple Sclerosis and Related Disorders. 53. 103034–103034. 7 indexed citations
10.
Kissani, Najib, Boulenouar Mesraoua, Fatema Abdulla, et al.. (2020). Epilepsy and school in the Middle East and North Africa (MENA) region: The current situation, challenges, and solutions. Epilepsy & Behavior. 112. 107325–107325. 3 indexed citations
11.
Alroughani, Raed, et al.. (2019). An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion. Neurology and Therapy. 8(1). 13–23. 22 indexed citations
12.
Gujjar, Arunodaya R., et al.. (2018). “Different Strokes”: A management dilemma. Sultan Qaboos University medical journal. 18(2). e202–207. 1 indexed citations
13.
Gujjar, Arunodaya R., et al.. (2017). Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study. Seizure. 49. 8–12. 44 indexed citations
14.
Nandhagopal, Ramachandiran, Sameer Raniga, Salam Alkindi, et al.. (2016). Non-traumatic Cerebral Fat Embolism in Sickle Cell Disease (P3.234). Neurology. 86(16_supplement). 1 indexed citations
15.
16.
Braidy, Nady, Selvaraju Subash, Musthafa Mohamed Essa, et al.. (2014). NEUROPROTECTIVE EFFECTS OF A VARIETY OF POMEGRANATE JUICE EXTRACTS (PJE) AGAINST THE EXCITOTOXIN QUINOLINIC ACID IN HUMAN PRIMARY NEURONS. The Journal of Prevention of Alzheimer s Disease. 1(2). 1–7. 1 indexed citations
17.
Gujjar, Arunodaya R., et al.. (2011). Transcranial doppler ultrasonography in acute ischemic stroke predicts stroke subtype and clinical outcome: a study in Omani population. Journal of Clinical Monitoring and Computing. 25(2). 121–128. 7 indexed citations
18.
Gujjar, Arunodaya R., et al.. (2009). Extrapontine myelinolysis as presenting manifestation of adrenal failure: A case report. Journal of the Neurological Sciences. 290(1-2). 169–171. 10 indexed citations
19.
Al‐Shafaee, Mohammed, Shyam S Ganguly, & Abdullah Al‐Asmi. (2006). Perception of stroke and knowledge of potential risk factors among Omani patients at increased risk for stroke. BMC Neurology. 6(1). 38–38. 66 indexed citations
20.
Andermann, Frédérick, Anna Jansen, Abdullah Al‐Asmi, & E. Andermann. (2005). Epilepsy in neuroacanthocytosis. Movement Disorders. 20. 1680–1680. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danuta Ryglewicz Breakdown of academic impact, for papers by Elyad Davidson Breakdown of academic impact, for papers by Seong A. Shin Breakdown of academic impact, for papers by Seung‐Hun Cho Breakdown of academic impact, for papers by Rubens José Gagliardi Breakdown of academic impact, for papers by M. Pappagallo Breakdown of academic impact, for papers by Maurizio Evangelista Breakdown of academic impact, for papers by Yu-Hui Liu Breakdown of academic impact, for papers by Anne Estrup Olesen Breakdown of academic impact, for papers by Ralf Uebelhack
Rankless by CCL
2026